DE69228061D1 - Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum - Google Patents
Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuumInfo
- Publication number
- DE69228061D1 DE69228061D1 DE69228061T DE69228061T DE69228061D1 DE 69228061 D1 DE69228061 D1 DE 69228061D1 DE 69228061 T DE69228061 T DE 69228061T DE 69228061 T DE69228061 T DE 69228061T DE 69228061 D1 DE69228061 D1 DE 69228061D1
- Authority
- DE
- Germany
- Prior art keywords
- galactose
- methods
- sulfate
- prediabetis
- itselves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK91846A DK84691D0 (da) | 1991-05-07 | 1991-05-07 | Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater |
PCT/DK1992/000146 WO1992019633A1 (en) | 1991-05-07 | 1992-05-07 | Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69228061D1 true DE69228061D1 (de) | 1999-02-11 |
DE69228061T2 DE69228061T2 (de) | 1999-05-27 |
Family
ID=8098211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69228061T Expired - Fee Related DE69228061T2 (de) | 1991-05-07 | 1992-05-07 | Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum |
Country Status (9)
Country | Link |
---|---|
US (1) | US5827828A (de) |
EP (1) | EP0584175B1 (de) |
JP (1) | JP3222465B2 (de) |
AT (1) | ATE175203T1 (de) |
AU (1) | AU1788892A (de) |
DE (1) | DE69228061T2 (de) |
DK (2) | DK84691D0 (de) |
ES (1) | ES2125898T3 (de) |
WO (1) | WO1992019633A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5580858A (en) * | 1991-06-10 | 1996-12-03 | Alberta Research Council | Immunosuppressive and tolerogenic modified Lewisx compounds |
CA2142153A1 (en) * | 1994-03-04 | 1995-09-05 | Jacques Banville | Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors |
US5663151A (en) * | 1994-03-04 | 1997-09-02 | Bristol-Myers Squibb Company | Sulfated α-glycolipid derivatives as cell adhesion inhibitors |
US5686426A (en) | 1994-11-17 | 1997-11-11 | Bristol-Myers Squibb Company | Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors |
SE9601817D0 (sv) | 1996-05-13 | 1996-05-13 | Karsten Buschard | Novel glycolipid complexex and their uses |
EP0988860B1 (de) * | 1997-04-10 | 2005-01-12 | Kirin Beer Kabushiki Kaisha | Verwendung von a-Glycosylceramiden zur Herstellung eines therapeutischen Mittelszur Behandlung von Autoimmunkrankheiten |
JP2001527046A (ja) | 1997-12-30 | 2001-12-25 | エイプラス サイエンス インベスト アーベー | ガラクトシルセラミド、グルコシルセラミド、ラクトシルセラミド、並びに前糖尿病、糖尿病および/または関連合併症の予防もしくは治療に使用するためのその特定キャッチャー |
SE0000258D0 (sv) * | 2000-01-27 | 2000-01-27 | A & Science Invest Ab | Pharmaceutical preparation and method for treatment of diabetes |
US8367623B2 (en) * | 2001-08-16 | 2013-02-05 | Japan As Represented By President Of National Center Of Neurology And Psychiatry | Glycolipid and medicine for autoimmune disease containing the same as active ingredient |
JP5564672B2 (ja) | 2006-06-30 | 2014-07-30 | ザ スクリプス リサーチ インスティテュート | アジュバント及びその使用方法 |
FR2926972B1 (fr) * | 2008-02-05 | 2011-03-11 | Technologia | Appareil de diagnostic precoce du syndrome du canal carpien et procede et dispositif d'acquisition de l'information relative a la sensibilite cutanee du doigt du patient |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288706A (en) * | 1987-12-25 | 1994-02-22 | Mitsui Toatsu Chemicals, Incorporated | Medicament for prevention and remedy of diseases of the pancreas and others |
-
1991
- 1991-05-07 DK DK91846A patent/DK84691D0/da not_active Application Discontinuation
-
1992
- 1992-05-07 AU AU17888/92A patent/AU1788892A/en not_active Abandoned
- 1992-05-07 DK DK92910435T patent/DK0584175T3/da active
- 1992-05-07 DE DE69228061T patent/DE69228061T2/de not_active Expired - Fee Related
- 1992-05-07 WO PCT/DK1992/000146 patent/WO1992019633A1/en active IP Right Grant
- 1992-05-07 EP EP92910435A patent/EP0584175B1/de not_active Expired - Lifetime
- 1992-05-07 ES ES92910435T patent/ES2125898T3/es not_active Expired - Lifetime
- 1992-05-07 JP JP51038492A patent/JP3222465B2/ja not_active Expired - Fee Related
- 1992-05-07 AT AT92910435T patent/ATE175203T1/de not_active IP Right Cessation
-
1995
- 1995-02-28 US US08/396,802 patent/US5827828A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE175203T1 (de) | 1999-01-15 |
DK0584175T3 (da) | 1999-08-30 |
JPH06506943A (ja) | 1994-08-04 |
DK84691D0 (da) | 1991-05-07 |
US5827828A (en) | 1998-10-27 |
WO1992019633A1 (en) | 1992-11-12 |
AU1788892A (en) | 1992-12-21 |
JP3222465B2 (ja) | 2001-10-29 |
ES2125898T3 (es) | 1999-03-16 |
DE69228061T2 (de) | 1999-05-27 |
EP0584175B1 (de) | 1998-12-30 |
EP0584175A1 (de) | 1994-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kochian et al. | Potassium transport in corn roots: I. Resolution of kinetics into a saturable and linear component | |
Bowers | Retreat from sanity: The structure of emerging psychosis. | |
DE69228061D1 (de) | Sulfatierte glykolipide, die eine galaktose-3-0-sulfate-gruppierung enthalten, und spezifische fänger für diese für die verwendung in der prophylaxe oder therapie der prädiabetis, diabetis und/oder damit zusammenhängender komplikationen in einem individuum | |
Grandjean et al. | Psychological dysfunctions in lead-exposed workers: relation to biological parameters of exposure | |
BR7608467A (pt) | Processo e dispositivo para teste de gravidez,bem como processo para detecao de condicoes fisiologicas associadas a presenca de gonadotropinas na urina ou no soro | |
Soffer et al. | Immunological factors and post coital test in unexplained infertility. | |
Rachman et al. | Is incomplete fear-reduction followed by a return of fear? | |
Paulev et al. | Motor nerve conduction velocity in asymptomatic lead workers | |
EP0259183A3 (de) | Verfahren zur Kontrolle der Genauigkeit und der Präzision von Empfindlichkeitstesten | |
Stork et al. | Pharmacokinetics of extended relief vs regular release Tylenol in simulated human overdose | |
Lorente et al. | A simple and reproducible method to evaluate granulocyte adherence | |
Magro | Blocking of histamine release from human basophils in vitro by the ATPase inhibitor, ethacrynic acid. | |
Speert et al. | Abnormalities of in vitro lymphocyte response to mitogens in diabetic children during acute ketoacidosis | |
Wang et al. | Plasma arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population | |
Weissgarten et al. | Induction of suppressor cells in normal lymphocytes by uremic serum | |
Richards et al. | Thyroid hormone and conditioning. | |
GR980300023T1 (en) | Means for treating auto-immune diseases and method of treatment | |
Sechrest et al. | Criminal activity, wages earned, and drug use after two years of methadone treatment. | |
JPS55119755A (en) | Processor providing test instruction function | |
JPS5443096A (en) | Sample vessel for electrolyte analyser | |
KR950703658A (ko) | Hiv감염자 및 그들의 처치 정도를 확인하는 방법 및 진단물질 | |
Lu | Solution of elastoplastic contact problem by boundary element method and mathematical programming technique | |
Temeck et al. | Bronchopulmonary dysplasia and allergy. | |
IE873143L (en) | HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF | |
Ernst | THE RADIATION SENSITIVITY OF CELL NUCLEOPROTEINS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |